SOPHiA GENETICS Says Jerusalem-Based Shaare Zedek Medical Center Uses SOPHiA DDM Platform To Advance Research of Myeloid Disorders
Portfolio Pulse from Benzinga Newsdesk
SOPHiA GENETICS announced that Jerusalem-based Shaare Zedek Medical Center is using its SOPHiA DDM platform to advance research of myeloid disorders. This could potentially increase the demand for SOPHiA's services.
September 29, 2023 | 10:10 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
SOPHiA GENETICS' DDM platform is being used by Shaare Zedek Medical Center for research. This could potentially increase the demand for SOPHiA's services and positively impact its stock price.
The use of SOPHiA GENETICS' DDM platform by a medical center for research purposes indicates a potential increase in demand for their services. This could lead to increased revenues and a positive impact on the company's stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100